Urine IP-10 as a biomarker of therapeutic response in patients with active pulmonary tuberculosis

Urine IP-10 as a biomarker of therapeutic response in patients with active pulmonary tuberculosis

Abstract Background Prior to clinical trials of new TB drugs or therapeutic vaccines, it is necessary to develop monitoring tools to predict treatment outcomes in TB patients. Urine interferon gamma inducible protein 10 (IP-10) is a potential biomarker of treatment response in chronic hepatitis C vi...

Full description

Bibliographic Details
Main Authors: Song Yee Kim, Jungho Kim, Deok Ryun Kim, Young Ae Kang, Sungyoung Bong, Jonghee Lee, Suyeon Kim, Nam Suk Lee, Bora Sim, Sang-Nae Cho, Young Sam Kim, Hyejon Lee
Format: Article
Language:English
Published: BMC 2018-05-01
Series:BMC Infectious Diseases
Subjects:
Tuberculosis
Urine IP-10
Biomarker
Monitoring
Online Access:http://link.springer.com/article/10.1186/s12879-018-3144-3

Internet

http://link.springer.com/article/10.1186/s12879-018-3144-3

Similar Items